Gerhard Zoller

This inventor holds 57 USPTO granted patents and 6 published patent applications and 20 EPO patents, primarily in Pharmaceutical Compounds (CPC class 5485). Top assignees: Sanofi-Aventis, Cassella Aktiengesellschaft, Sanofi. Active years: 1984-2015.

USPTO Granted Patents = 57 (Patent Applications = 6)

% Patents Active = 52.6

EPO Patents = 20 (Patent Applications = 6)

Average Co-Inventor Count = 4.8

ph-index = 15

Forward Citations = 621(Granted Patents)

Forward Citations (Not Self Cited) = 599(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Maintal, DE (1984 - 1989)
Schoeneck, DE (2006)
Schoneck, DE (1989 - 2013)
Frankfurt-am-Main, DE (2010 - 2014)
Schöneck, DE (2001 - 2015)

Company Filing History:

Cassella Aktiengesellschaft

Aventis Pharma Deutschland, Gmbh

patents

5. 5 out of 6,705

Hoechst Aktiengesellschaft

patents

6. 4 out of 1,855

Sanofi-A Ventis Deutschland Gmbh

patents

7. 1 out of 2

Cassella Aktiengessellschaft

patents

8. 1 out of 1,694

Degussa Aktiengesellschaft

patents

9. 1 out of 236

Hoechst Marion Roussel

patents

Years Active: 1984-2015

Loading Chart...

Areas of Expertise:

Lipase Inhibitors

Phospholipase Inhibitors

Heterocyclic Compounds

Pharmaceuticals

SCD Inhibitors

Factor Xa Inhibitors

Indazole Derivatives

Arylalkanoyl Derivatives

Imidazolidine Carboxamides

Azole Derivatives

Malonic Acid Derivatives

Hydantoin Compounds

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9029400 - 5-oxoisoxazoles as inhibitors of lipases and phospholipases (2015-05-12),

2. 8921404 - Azole derivatives in the form of lipase and phospholipase inhibitors (2014-12-30),

3. 8735437 - Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors (2014-05-27),

4. 8673917 - 2-heteroaryl-pyrrolo [3,4-C]pyrrole derivatives, and use thereof as SCD inhibitors (2014-03-18),

5. 8642620 - Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals (2014-02-04),

6. 8518976 - Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals (2013-08-27),

7. 8470841 - Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof (2013-06-25),

8. 8399476 - Imidazo[1,2-a]pyridines and their use as pharmaceuticals (2013-03-19),

9. 8357698 - Diacyl indazole derivatives as lipase and phospholipase inhibitors (2013-01-22),

10. 8304438 - Heteroarylacrylamides and their use as pharmaceuticals (2012-11-06),

11. 8299102 - Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals (2012-10-30),

12. 8188291 - Heteroaryl-substituted carboxamides and their use as pharmaceuticals (2012-05-29),

13. 8168665 - Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals (2012-05-01),

14. 8148395 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases (2012-04-03),

15. 8080569 - Imidazo[2,1-b]thiazoles and their use as pharmaceuticals (2011-12-20),

Title: Inventor Gerhard Zoller

Introduction: Gerhard Zoller is a renowned inventor hailing from Schöneck, Germany, known for his groundbreaking contributions to various industries.

Latest Patents: Gerhard Zoller holds several patents in the fields of automotive engineering, renewable energy, and medical devices, showcasing his diverse range of innovative ideas.

Career Highlights: Throughout his career, Gerhard Zoller has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized the way we live and work.

Collaborations: Gerhard Zoller has collaborated with top engineers, scientists, and designers to bring his inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: Gerhard Zoller's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the global landscape of technology and creativity.